4 Result(s)

Article

Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective

Bradley M. Sugden, Sabine E. Grimm, Robert Wolff, Nigel Armstrong… in PharmacoEconomics (2024)

Article

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Celgene) of lenalidomide (Revlimid^®), as part of the Single Technology Appraisal (STA) process, to submit evidence for the cl...

Willem J. A. Witlox, Sabine E. Grimm, Rob Riemsma, Nigel Armstrong… in PharmacoEconomics (2021)

Article

Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

As part of the Single Technology Appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer (AstraZeneca) of durvalumab (IMFINZI^TM) to submit evidence for the c...

Willem J. A. Witlox, Antoinette D. I. van Asselt, Robert Wolff… in PharmacoEconomics (2020)

Article

An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies

The role of diet in bladder carcinogenesis has yet to be established. To date most studies have investigated dietary components individually, rather than as dietary patterns, which may provide stronger evidenc...

Willem J. A. Witlox, Frits H. M. van Osch, Maree Brinkman… in European Journal of Nutrition (2020)